Induction of the SOS response by new 4-quinolones.

DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev (1997) 9.69

Fluoroquinolone antimicrobial agents. Clin Microbiol Rev (1989) 6.45

Autolysis and autoaggregation in Pseudomonas aeruginosa colony morphology mutants. J Bacteriol (2002) 4.04

Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother (2000) 3.27

Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol (2010) 3.12

DNA topoisomerase targets of the fluoroquinolones: a strategy for avoiding bacterial resistance. Proc Natl Acad Sci U S A (1997) 2.99

Fluoroquinolone action against mycobacteria: effects of C-8 substituents on growth, survival, and resistance. Antimicrob Agents Chemother (1998) 2.35

Functional relationship between bacterial cell density and the efficacy of antibiotics. J Antimicrob Chemother (2009) 2.24

beta-lactam antibiotics induce the SOS response and horizontal transfer of virulence factors in Staphylococcus aureus. J Bacteriol (2006) 2.07

Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? Clin Microbiol Rev (2013) 2.01

Mutants of Escherichia coli K-12 exhibiting reduced killing by both quinolone and beta-lactam antimicrobial agents. Antimicrob Agents Chemother (1990) 1.97

Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy. Clin Microbiol Rev (2006) 1.82

The complete genome sequence of Xanthomonas albilineans provides new insights into the reductive genome evolution of the xylem-limited Xanthomonadaceae. BMC Genomics (2009) 1.71

Bacterial topoisomerase I as a target for discovery of antibacterial compounds. Nucleic Acids Res (2008) 1.55

Correlation of quinolone MIC and inhibition of DNA, RNA, and protein synthesis and induction of the SOS response in Escherichia coli. Antimicrob Agents Chemother (1990) 1.46

SOS-independent induction of dinB transcription by beta-lactam-mediated inhibition of cell wall synthesis in Escherichia coli. J Bacteriol (2005) 1.46

Adaptive mutations produce resistance to ciprofloxacin. Antimicrob Agents Chemother (1997) 1.37

Bactericidal activities of five quinolones for Escherichia coli strains with mutations in genes encoding the SOS response or cell division. Antimicrob Agents Chemother (1992) 1.23

Prevalence of SOS-mediated control of integron integrase expression as an adaptive trait of chromosomal and mobile integrons. Mob DNA (2011) 1.20

Activity of quinolones in the Ames Salmonella TA102 mutagenicity test and other bacterial genotoxicity assays. Antimicrob Agents Chemother (1993) 1.16

Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or -independent pathways, respectively. Antimicrob Agents Chemother (2006) 1.14

Role of autofluorescence in flow cytometric analysis of Escherichia coli treated with bactericidal antibiotics. J Bacteriol (2013) 1.09

In vitro cleavable-complex assay to monitor antimicrobial potency of quinolones. Antimicrob Agents Chemother (1988) 1.08

SB 205952, a novel semisynthetic monic acid analog with at least two modes of action. Antimicrob Agents Chemother (1995) 1.07

Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (1993) 1.06

Flow cytometric investigation of filamentation, membrane patency, and membrane potential in Escherichia coli following ciprofloxacin exposure. Antimicrob Agents Chemother (2000) 1.06

Mycobacterium tuberculosis DNA repair in response to subinhibitory concentrations of ciprofloxacin. J Antimicrob Chemother (2008) 1.05

Role of lon, an ATP-dependent protease homolog, in resistance of Pseudomonas aeruginosa to ciprofloxacin. Antimicrob Agents Chemother (2007) 1.04

Isolation and characterization of an Escherichia coli strain exhibiting partial tolerance to quinolones. Antimicrob Agents Chemother (1989) 1.01

Ex vivo antibacterial properties of rufloxacin compared with those of norfloxacin in a study with healthy volunteers. Antimicrob Agents Chemother (1996) 0.99

Hydroxyl radicals are involved in cell killing by the bacterial topoisomerase I cleavage complex. J Bacteriol (2009) 0.94

Analysis of macromolecular biosynthesis to define the quinolone-induced postantibiotic effect in Escherichia coli. Antimicrob Agents Chemother (1992) 0.90

Antibiotic treatment enhances the genome-wide mutation rate of target cells. Proc Natl Acad Sci U S A (2016) 0.90

Discovery and development of new antimicrobial agents. Clin Microbiol Rev (1990) 0.87

The strictly conserved Arg-321 residue in the active site of Escherichia coli topoisomerase I plays a critical role in DNA rejoining. J Biol Chem (2011) 0.87

Sensitization of bacteria to danofloxacin by temperate prophages. Antimicrob Agents Chemother (1996) 0.85

Persister Development by Borrelia burgdorferi Populations In Vitro. Antimicrob Agents Chemother (2015) 0.85

Sublethal concentrations of ciprofloxacin induce bacteriocin synthesis in Escherichia coli. Antimicrob Agents Chemother (2005) 0.84

Increased expression of ampC in Pseudomonas aeruginosa mutants selected with ciprofloxacin. Antimicrob Agents Chemother (2007) 0.84

Global transcriptome and physiological responses of Acinetobacter oleivorans DR1 exposed to distinct classes of antibiotics. PLoS One (2014) 0.81

Pharmacodynamic effects of subinhibitory concentrations of rufloxacin on bacterial virulence factors. Antimicrob Agents Chemother (1999) 0.81

Characterization of stress-responsive behavior in Pseudomonas aeruginosa PAO: isolation of Tn3-lacZYA fusions with novel damage-inducible (din) promoters. J Bacteriol (1992) 0.80

SOS response activation and competence development are antagonistic mechanisms in Streptococcus thermophilus. J Bacteriol (2012) 0.79

Targeting bacterial topoisomerase I to meet the challenge of finding new antibiotics. Future Med Chem (2015) 0.79

Mutational Consequences of Ciprofloxacin in Escherichia coli. Antimicrob Agents Chemother (2016) 0.75

Peptoids successfully inhibit the growth of gram negative E. coli causing substantial membrane damage. Sci Rep (2017) 0.75

The Role of Antibiotics in Modulating Virulence in Staphylococcus aureus. Clin Microbiol Rev (2017) 0.75

The global regulatory protein CRP controls multifactorial fluoroquinolone susceptibility in Salmonella enterica serovar Typhimurium. Antimicrob Agents Chemother (2017) 0.75

Comparative genomics of Listeria species. Science (2001) 12.94

High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science (2000) 9.14

Expression in Escherichia coli and sequence analysis of the listeriolysin O determinant of Listeria monocytogenes. Infect Immun (1988) 6.74

Listeriolysin O is essential for virulence of Listeria monocytogenes: direct evidence obtained by gene complementation. Infect Immun (1989) 5.04

Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity? Clin Infect Dis (2007) 4.51

Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe. Euro Surveill (2008) 4.03

Pleiotropic mutations rendering Escherichia coli K-12 resistant to bacteriophage TP1. J Bacteriol (1980) 3.31

Mutation frequencies and antibiotic resistance. Antimicrob Agents Chemother (2000) 3.27

An E. coli promoter induced by the cessation of growth. Mol Microbiol (1987) 3.26

The export of the DNA replication inhibitor Microcin B17 provides immunity for the host cell. EMBO J (1988) 3.25

Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect (2008) 3.18

Gene sequence and biochemical characterization of FOX-1 from Klebsiella pneumoniae, a new AmpC-type plasmid-mediated beta-lactamase with two molecular variants. Antimicrob Agents Chemother (1994) 3.09

Nucleotide sequence and characterization of a novel cefotaxime-hydrolyzing beta-lactamase (CTX-M-10) isolated in Spain. Antimicrob Agents Chemother (2001) 2.91

Microcin plasmids: a group of extrachromosomal elements coding for low-molecular-weight antibiotics in Escherichia coli. J Bacteriol (1978) 2.83

Antibiotics as intermicrobial signaling agents instead of weapons. Proc Natl Acad Sci U S A (2006) 2.80

Mycobacterium tuberculosis subsp. caprae subsp. nov.: a taxonomic study of a new member of the Mycobacterium tuberculosis complex isolated from goats in Spain. Int J Syst Bacteriol (1999) 2.63

Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrob Agents Chemother (2001) 2.42

Genetic analysis of bacteriophage phi 29 of Bacillus subtilis: integration and mapping of reference mutants of two collections. J Virol (1976) 2.38

Genetics of ribosomally synthesized peptide antibiotics. Annu Rev Microbiol (1992) 2.35

Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Antimicrob Agents Chemother (1993) 2.34

Phenotypic tolerance: antibiotic enrichment of noninherited resistance in bacterial populations. Antimicrob Agents Chemother (2005) 2.20

Bacillus subtilis phage phi29. Characterization of gene products and functions. Eur J Biochem (1976) 2.17

Growth phase and ompR regulation of transcription of microcin B17 genes. J Bacteriol (1986) 2.15

Factors determining resistance to beta-lactam combined with beta-lactamase inhibitors in Escherichia coli. J Antimicrob Chemother (1991) 2.12

A novel deletion involving the connexin-30 gene, del(GJB6-d13s1854), found in trans with mutations in the GJB2 gene (connexin-26) in subjects with DFNB1 non-syndromic hearing impairment. J Med Genet (2005) 2.11

DNA sequence, products, and transcriptional pattern of the genes involved in production of the DNA replication inhibitor microcin B17. J Bacteriol (1989) 2.07

The peptide antibiotic microcin B17 induces double-strand cleavage of DNA mediated by E. coli DNA gyrase. EMBO J (1991) 2.04

Suppressor-sensitive mutants and genetic map of Bacillus subtilis bacteriophage phi 29. Virology (1974) 2.01

A signal sequence is not sufficient to lead beta-galactosidase out of the cytoplasm. Nature (1980) 2.00

New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak. Antimicrob Agents Chemother (1995) 1.99

Transmission between HIV-infected patients of multidrug-resistant tuberculosis caused by Mycobacterium bovis. AIDS (1997) 1.98

European recommendations for antimicrobial resistance surveillance. Clin Microbiol Infect (2004) 1.95

Plasmids in Listeria. Plasmid (1982) 1.94

Cloning and mapping of the genetic determinants for microcin B17 production and immunity. J Bacteriol (1985) 1.90

Microcin B17 blocks DNA replication and induces the SOS system in Escherichia coli. J Gen Microbiol (1986) 1.89

Molecular analysis of the SMN and NAIP genes in Spanish spinal muscular atrophy (SMA) families and correlation between number of copies of cBCD541 and SMA phenotype. Hum Mol Genet (1996) 1.83

The DNA replication inhibitor microcin B17 is a forty-three-amino-acid protein containing sixty percent glycine. Proteins (1986) 1.80

Identification, mapping, cloning and characterization of a gene (sbmA) required for microcin B17 action on Escherichia coli K12. J Gen Microbiol (1986) 1.79

Ten novel mutations in the NR5A1 gene cause disordered sex development in 46,XY and ovarian insufficiency in 46,XX individuals. J Clin Endocrinol Metab (2012) 1.78

In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob Agents Chemother (2001) 1.74

Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: antibiotic use as risk factor for colonization and infection. Clin Infect Dis (2000) 1.74

Chemical structure and translation inhibition studies of the antibiotic microcin C7. J Biol Chem (1995) 1.73

Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and beta-lactam consumption in Spain (1979-1997). J Antimicrob Chemother (2000) 1.72

Genetic characterization of multidrug-resistant Mycobacterium bovis strains from a hospital outbreak involving human immunodeficiency virus-positive patients. J Clin Microbiol (1997) 1.72

vanA-mediated vancomycin-resistant Enterococcus spp. in sewage. J Antimicrob Chemother (1994) 1.71

Gene ompR and regulation of microcin 17 and colicin e2 syntheses. J Bacteriol (1982) 1.70

Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase. J Med Chem (1998) 1.70

Mutations in a new gene encoding a protein of the hair bundle cause non-syndromic deafness at the DFNB16 locus. Nat Genet (2001) 1.68

Lens injuries induced by occupational exposure in non-optimized interventional radiology laboratories. Br J Radiol (1998) 1.66

Allele-specific PCR method based on pncA and oxyR sequences for distinguishing Mycobacterium bovis from Mycobacterium tuberculosis: intraspecific M. bovis pncA sequence polymorphism. J Clin Microbiol (1998) 1.66

The transposon Tn5 carries a bleomycin-resistance determinant. Gene (1984) 1.65

The cyclic structure of microcin J25, a 21-residue peptide antibiotic from Escherichia coli. Eur J Biochem (1999) 1.64

Antibiotic resistance in Campylobacter strains isolated from animals, foods, and humans in Spain in 1997-1998. Antimicrob Agents Chemother (2000) 1.64

Evaluation of the Wider system, a new computer-assisted image-processing device for bacterial identification and susceptibility testing. J Clin Microbiol (2000) 1.62

Plasmid genes required for microcin B17 production. J Bacteriol (1985) 1.59

Sequence analysis of the four plasmid genes required to produce the circular peptide antibiotic microcin J25. J Bacteriol (1999) 1.57

An unusual mechanism for resistance to the antibiotic coumermycin A1. Proc Natl Acad Sci U S A (1991) 1.57

Transposition of the great arteries with posterior aorta, anterior pulmonary artery, subpulmonary conus and fibrous continuity between aortic and atrioventricular valves. Am J Cardiol (1971) 1.57

appR gene product activates transcription of microcin C7 plasmid genes. J Bacteriol (1989) 1.56

A genotype-phenotype correlation for GJB2 (connexin 26) deafness. J Med Genet (2004) 1.56

Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance. Antimicrob Agents Chemother (2000) 1.55

Resistance to beta-lactam/clavulanate. Lancet (1987) 1.54

The colicin G, H and X determinants encode microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN. Microbiology (2003) 1.54

Cloning and mapping of the genetic determinants for microcin C7 production and immunity. J Bacteriol (1986) 1.53

International collaborative study on standardization of bacterial sensitivity to fosfomycin. J Antimicrob Chemother (1983) 1.52

Hepatitis E virus: relevance in blood donors and other risk groups. Vox Sang (1998) 1.51

Structure and organization of plasmid genes required to produce the translation inhibitor microcin C7. J Bacteriol (1995) 1.51

Biological cost of AmpC production for Salmonella enterica serotype Typhimurium. Antimicrob Agents Chemother (2000) 1.50

Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother (2000) 1.48

Postantibiotic effect of imipenem on gram-positive and gram-negative micro-organisms. J Antimicrob Chemother (1986) 1.46

The Escherichia coli K-12 sheA gene encodes a 34-kDa secreted haemolysin. Mol Microbiol (1997) 1.45

Mechanisms of iron acquisition and bacterial virulence. FEMS Microbiol Rev (1990) 1.44

The hexokinase 2 protein regulates the expression of the GLK1, HXK1 and HXK2 genes of Saccharomyces cerevisiae. Biochem J (2001) 1.44

In vitro activity of linezolid against Mycobacterium tuberculosis complex, including multidrug-resistant Mycobacterium bovis isolates. Int J Antimicrob Agents (2006) 1.42

mprA, an Escherichia coli gene that reduces growth-phase-dependent synthesis of microcins B17 and C7 and blocks osmoinduction of proU when cloned on a high-copy-number plasmid. J Bacteriol (1990) 1.42

Transcriptional regulation of the Saccharomyces cerevisiae HXK1, HXK2 and GLK1 genes. Yeast (1995) 1.42

Selective immediate allergic response to penicillin V. Allergy (1996) 1.41

dacD, an Escherichia coli gene encoding a novel penicillin-binding protein (PBP6b) with DD-carboxypeptidase activity. J Bacteriol (1996) 1.40

The emergence of highly fluoroquinolone-resistant Escherichia coli in community-acquired urinary tract infections. J Antimicrob Chemother (1992) 1.40

beta-Lactam coselection of sensitive and TEM-1 beta-lactamase-producing subpopulations in heterogeneous Escherichia coli colonies. J Antimicrob Chemother (1985) 1.40

Single amino acid replacements at positions altered in naturally occurring extended-spectrum TEM beta-lactamases. Antimicrob Agents Chemother (1995) 1.40

An extended-spectrum AmpC-type beta-lactamase obtained by in vitro antibiotic selection. FEMS Microbiol Lett (1998) 1.40

Splicing mutations of the polycystic kidney disease 1 (PKD1) gene induced by intronic deletion. Hum Mol Genet (1995) 1.39

Magnetic and electric coherence in forward- and back-scattered electromagnetic waves by a single dielectric subwavelength sphere. Nat Commun (2012) 1.39

The smallest known gene. Nature (1994) 1.38

Microcin H47, a chromosome-encoded microcin antibiotic of Escherichia coli. J Bacteriol (1990) 1.37

Antibiotic therapy of community respiratory tract infections: strategies for optimal outcomes and minimized resistance emergence. J Antimicrob Chemother (2002) 1.37

Healthcare-associated infections: think globally, act locally. Clin Microbiol Infect (2008) 1.35

Erythromycin and clindamycin resistance and telithromycin susceptibility in Streptococcus agalactiae. Antimicrob Agents Chemother (2003) 1.34

Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill (2011) 1.34

Q829X, a novel mutation in the gene encoding otoferlin (OTOF), is frequently found in Spanish patients with prelingual non-syndromic hearing loss. J Med Genet (2002) 1.34

Genetic analysis of microcin H47 antibiotic system. J Bacteriol (1993) 1.34

Changes in quality of life after renal transplantation. Am J Kidney Dis (1998) 1.31

Small plasmids are involved in amoxicillin-clavulanate resistance in Escherichia coli. Antimicrob Agents Chemother (1989) 1.31

Implication of Ile-69 and Thr-182 residues in kinetic characteristics of IRT-3 (TEM-32) beta-lactamase. Antimicrob Agents Chemother (1996) 1.30

Nucleotide sequence of the Escherichia coli regulatory gene mprA and construction and characterization of mprA-deficient mutants. J Bacteriol (1991) 1.30

Inhibition of nuclear factor kappaB activation by a virus-encoded IkappaB-like protein. J Biol Chem (1998) 1.30

A suppressor of nonsense mutations in Bacillus subtilis. Eur J Biochem (1974) 1.30

Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis. J Infect Dis (1996) 1.29